Schonfeld Strategic Advisors’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
897,388
+695,673
| +345% | +$856K | 0.01% | 1184 |
|
|
2025
Q1 | $222K | Buy |
201,715
+47,015
| +30% | +$51.7K | ﹤0.01% | 1777 |
|
|
2024
Q4 | $140K | Sell |
154,700
-81,900
| -35% | -$74.1K | ﹤0.01% | 1747 |
|
|
2024
Q3 | $233K | Sell |
236,600
-919,636
| -80% | -$907K | ﹤0.01% | 1611 |
|
|
2024
Q2 | $1.04M | Buy |
1,156,236
+975,678
| +540% | +$879K | 0.01% | 1070 |
|
|
2024
Q1 | $213K | Sell |
180,558
-189,102
| -51% | -$223K | ﹤0.01% | 1575 |
|
|
2023
Q4 | $337K | Buy |
369,660
+9,760
| +3% | +$8.91K | ﹤0.01% | 1316 |
|
|
2023
Q3 | $300K | Sell |
359,900
-25,500
| -7% | -$21.2K | ﹤0.01% | 1196 |
|
|
2023
Q2 | $462K | Sell |
385,400
-6,400
| -2% | -$7.68K | ﹤0.01% | 1215 |
|
|
2023
Q1 | $494K | Sell |
391,800
-511,700
| -57% | -$645K | ﹤0.01% | 1157 |
|
|
2022
Q4 | $1.96M | Buy |
903,500
+774,156
| +599% | +$1.68M | 0.02% | 826 |
|
|
2022
Q3 | $1.55M | Buy |
129,344
+91,568
| +242% | +$1.1M | 0.01% | 993 |
|
|
2022
Q2 | $315K | Sell |
37,776
-57,824
| -60% | -$482K | ﹤0.01% | 1562 |
|
|
2022
Q1 | $830K | Sell |
95,600
-26,900
| -22% | -$234K | 0.01% | 1025 |
|
|
2021
Q4 | $1.39M | Buy |
122,500
+22,200
| +22% | +$251K | 0.01% | 747 |
|
|
2021
Q3 | $1.26M | Buy |
+100,300
| New | +$1.26M | 0.01% | 803 |
|
|
2021
Q2 | – | Sell |
-49,902
| Closed | -$461K | – | 2026 |
|
|
2021
Q1 | $461K | Buy |
49,902
+6,060
| +14% | +$56K | 0.01% | 1138 |
|
|
2020
Q4 | $423K | Buy |
+43,842
| New | +$423K | 0.01% | 1058 |
|